Business Context and Reporting Period
This Form 8-K filing by iSpecimen Inc. (ISPC) reports on events occurring on January 23, 2026, regarding the company's 2025 Annual Meeting of Stockholders. The filing was signed on January 27, 2026, by Katharyn Field, Chief Executive Officer.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance events and does not contain financial performance data.
Material Changes
The primary material event reported is the failure to achieve a quorum at the reconvened 2025 Annual Meeting held on January 23, 2026. This follows a previous adjournment of the meeting on December 31, 2025, for the same reason. Consequently, no votes were cast on the proposals outlined in the definitive proxy statement filed on November 21, 2025.
Guidance, Outlook, and Risks
Outlook and Next Steps: The Company intends to reconvene the Annual Meeting on February 13, 2026. The record date for the meeting remains November 3, 2025.
Risks and Contingencies: The repeated inability to secure a quorum presents a risk to the timely approval of stockholder proposals and corporate governance matters. The filing does not disclose other specific risks, contingencies, or unusual items.
Key Facts for Investor Verification
- The 2025 Annual Meeting was adjourned twice (December 31, 2025, and January 23, 2026) due to a lack of quorum.
- The next scheduled reconvened meeting is set for February 13, 2026.
- The record date for voting eligibility remains November 3, 2025.
- No financial results or operational metrics are included in this specific filing.